Scinovex
article Open AccessTop 1% cited

Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21

Cell Metabolism · 2007 · Vol. 5(6) · pp. 415–425
Takeshi InagakiPaul A. DutchakGuixiang ZhaoXunshan DingLaurent GautronVinay ParameswaraYong LiRegina GoetzMoosa MohammadiVictoria EsserJoel K. ElmquistRobert D. GerardShawn C. BurgessRobert E. HammerDavid J. MangelsdorfSteven A. Kliewer
Fibroblast Growth Factor ResearchPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and MetabolismEndocrine systemEndocrinologyFGF21Fibroblast growth factorInternal medicinePeroxisome proliferator-activated receptorFibroblastMedicineHormoneCell biology

MeSH terms

AdenoviridaeAdipose TissueAnimalsCells, CulturedFastingFemaleFibroblast Growth FactorsHumansLipolysisLiverMaleMice, Inbred C57BLMice, TransgenicPlasmidsRNA, Messenger

Funding

  • University of Texas Southwestern Medical Center
  • National Institutes of Health
Citations
1,480
FWCI
21.45
field-weighted impact
References
57
Percentile
100%
vs. same field & year
Citations per year
Cited by
Therapeutic potential of FGF21 in diabetes
Journal of Medicinal Plants Studies · 2017 · 4 citations
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2020 · 440 citations
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Endocrinology · 2008 · 1,010 citations
Ketone body metabolism and cardiovascular disease
American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 442 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.